236 related articles for article (PubMed ID: 19121065)
1. Multiple components contribute to ability of saliva to inhibit influenza viruses.
White MR; Helmerhorst EJ; Ligtenberg A; Karpel M; Tecle T; Siqueira WL; Oppenheim FG; Hartshorn KL
Oral Microbiol Immunol; 2009 Feb; 24(1):18-24. PubMed ID: 19121065
[TBL] [Abstract][Full Text] [Related]
2. Comparison of proteins with anti-influenza virus effects in parotid and submandibular-sublingual saliva in humans.
Yamamoto K; Yamamoto S
BMC Oral Health; 2022 Dec; 22(1):639. PubMed ID: 36566172
[TBL] [Abstract][Full Text] [Related]
3. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation.
Hartshorn KL; Ligtenberg A; White MR; Van Eijk M; Hartshorn M; Pemberton L; Holmskov U; Crouch E
Biochem J; 2006 Jan; 393(Pt 2):545-53. PubMed ID: 16190864
[TBL] [Abstract][Full Text] [Related]
4. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor.
White MR; Crouch E; van Eijk M; Hartshorn M; Pemberton L; Tornoe I; Holmskov U; Hartshorn KL
Am J Physiol Lung Cell Mol Physiol; 2005 May; 288(5):L831-40. PubMed ID: 15608147
[TBL] [Abstract][Full Text] [Related]
5. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D.
Hartshorn KL; White MR; Tecle T; Holmskov U; Crouch EC
J Immunol; 2006 Jun; 176(11):6962-72. PubMed ID: 16709857
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.
Bolscher JG; Nazmi K; Ran LJ; van Engelenburg FA; Schuitemaker H; Veerman EC; Nieuw Amerongen AV
Eur J Oral Sci; 2002 Apr; 110(2):149-56. PubMed ID: 12013559
[TBL] [Abstract][Full Text] [Related]
7. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses.
Hartshorn KL; White MR; Mogues T; Ligtenberg T; Crouch E; Holmskov U
Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1066-76. PubMed ID: 12871854
[TBL] [Abstract][Full Text] [Related]
8. Identification of histatins as tannin-binding proteins in human saliva.
Yan Q; Bennick A
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):341-7. PubMed ID: 7575474
[TBL] [Abstract][Full Text] [Related]
9. Histatins enhance wound closure with oral and non-oral cells.
Oudhoff MJ; van den Keijbus PA; Kroeze KL; Nazmi K; Gibbs S; Bolscher JG; Veerman EC
J Dent Res; 2009 Sep; 88(9):846-50. PubMed ID: 19767583
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.
Job ER; Bottazzi B; Gilbertson B; Edenborough KM; Brown LE; Mantovani A; Brooks AG; Reading PC
PLoS One; 2013; 8(3):e59623. PubMed ID: 23544079
[TBL] [Abstract][Full Text] [Related]
11. Aggregation of human immunodeficiency virus type 1 by human salivary secretions.
Bergey EJ; Cho MI; Hammarskjöld ML; Rekosh D; Levine MJ; Blumberg BM; Epstein LG
Crit Rev Oral Biol Med; 1993; 4(3-4):467-74. PubMed ID: 8373999
[TBL] [Abstract][Full Text] [Related]
12. The comparative inhibitory potency of salivary mucins against human immunodeficiency virus type 1.
McQuaid IK; Dorfman JR; Mall AS
Virology; 2021 Jan; 553():1-8. PubMed ID: 33190061
[TBL] [Abstract][Full Text] [Related]
13. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses.
Verma A; White M; Vathipadiekal V; Tripathi S; Mbianda J; Ieong M; Qi L; Taubenberger JK; Takahashi K; Jensenius JC; Thiel S; Hartshorn KL
J Immunol; 2012 Sep; 189(5):2478-87. PubMed ID: 22851708
[TBL] [Abstract][Full Text] [Related]
14. Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D.
Hartshorn KL; White MR; Tecle T; Tornoe I; Sorensen GL; Crouch EC; Holmskov U
Respir Res; 2007 Feb; 8(1):9. PubMed ID: 17280604
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of influenza viral neuraminidase activity by collectins.
Tecle T; White MR; Crouch EC; Hartshorn KL
Arch Virol; 2007; 152(9):1731-42. PubMed ID: 17514488
[TBL] [Abstract][Full Text] [Related]
16. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.
Tripathi S; Tecle T; Verma A; Crouch E; White M; Hartshorn KL
J Gen Virol; 2013 Jan; 94(Pt 1):40-49. PubMed ID: 23052388
[TBL] [Abstract][Full Text] [Related]
17. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
[TBL] [Abstract][Full Text] [Related]
18. Effect of donor age on the concentrations of histatins in human parotid and submandibular/sublingual saliva.
Johnson DA; Yeh CK; Dodds MW
Arch Oral Biol; 2000 Sep; 45(9):731-40. PubMed ID: 10869486
[TBL] [Abstract][Full Text] [Related]
19. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
20. Adsorption of human salivary proteins to hydroxyapatite: a comparison between whole saliva and glandular salivary secretions.
Jensen JL; Lamkin MS; Oppenheim FG
J Dent Res; 1992 Sep; 71(9):1569-76. PubMed ID: 1381733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
